# US 2006/0068383 A1 · Kits for the detection of target sequences

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0068383 A1
- Document ID: US20060068383A1
- Status: Published application
- Kind: A1
- Application number: 09/941,095
- Filed: 2001-08-28
- Published: 2006-03-30
- Earliest claimed: 1992-12-07
- Assignees: Third Wave Technologies, Inc.
- Inventors: James Dahlberg; Mary Brow; Victor Lyamichev
- Web page: https://patentgrep.com/patent/US20060068383A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07K 14/4746: {p53}
- C07K 14/82: Translation products from oncogenes
- C12N 9/1252: {DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase}
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12Q 1/68: involving nucleic acids
- C12Q 1/682: Signal amplification
- C12Q 1/6823: Release of bound markers
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/683: involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
- C12Q 1/6853: using modified primers or templates
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/689: for bacteria
- C12Q 1/705: {for herpetoviridae, e.g. herpes simplex, varicella zoster}
- Y10T 436/143333: Saccharide [e.g., DNA, etc.]
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention relates to means for cleaving a nucleic acid cleavage structure in a site-specific manner. Enzymes, including 5′ nucleases and 3′ exonucleases, are used to detect and identify nucleic acids derived from microorganisms. Methods are provided which allow for the detection and identification of bacterial and viral pathogens in a sample.

## Claims

### Claim 1

A method for identifying strains of microorganisms comprising:
a) providing
i) a cleavage means; and
ii) a nucleic acid substrate containing sequences derived from one or more microorganism;
b) treating said nucleic acid substrate under conditions such that said substrate forms one or more cleavage structures; and
c) reacting said cleavage means with said cleavage structures so that one or more cleavage products are produced.

### Claim 2 (depends on 1)

The method of claim 1, wherein said cleavage means is an enzyme.

### Claim 3 (depends on 2)

The method of claim 2, wherein said enzyme is a nuclease.

### Claim 4 (depends on 3)

The method of claim 3, wherein said nuclease is selected from the group consisting of Cleavase™ BN, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and the Saccharomyces cerevisiae Rad1/Rad10 complex.

### Claim 5 (depends on 1)

The method of claim 1, wherein said nucleic acid substrate comprises a nucleotide analog.

### Claim 6 (depends on 5)

The method of claim 5, wherein said nucleotide analog is selected from the group comprising 7-deaza-dATP, 7-deaza-dGTP and dUTP.

### Claim 7 (depends on 1)

The method of claim 1, wherein said nucleic acid of step (a) is substantially single-stranded.

### Claim 8 (depends on 1)

The method of claim 1, wherein said nucleic acid is RNA.

### Claim 9 (depends on 1)

The method of claim 1, wherein said nucleic acid is DNA.

### Claim 10 (depends on 1)

The method of claim 1, wherein said nucleic acid of step (a) is double stranded.

### Claim 11 (depends on 10)

The method of claim 10, wherein said treating of step (b) comprises:
i) rendering said double-stranded nucleic acid substantially single-stranded; and
ii) exposing said single-stranded nucleic acid to conditions such that said single-stranded nucleic acid has secondary structure.

### Claim 12 (depends on 11)

The method of claim 11, wherein said double-stranded nucleic acid is rendered substantially single-stranded by increased temperature.

### Claim 13 (depends on 1)

The method of claim 1, further comprising the step of detecting said one or more cleavage products.

### Claim 14 (depends on 1)

The method of claim 1 wherein said microorganism comprises bacteria.

### Claim 15 (depends on 14)

The method of claim 14 wherein said bacteria are selected from the group comprising members of the genera Campylobacter, Escherichia, Mycobacterium, Salmonella, Shigella and Staphylococcus.

### Claim 16 (depends on 15)

The method of claim 15 wherein said members of the genus Mycobacterium comprise strains of multi-drug resistant Mycobacterium tuberculosis.

### Claim 17 (depends on 1)

The method of claim 1 wherein said microorganism comprises virus.

### Claim 18 (depends on 17)

The method of claim 17 wherein said virus is selected from the group comprising hepatitis C virus and simian immunodeficiency virus.

### Claim 19

A method for detecting and identifying strains of microorganisms, comprising:
a) extracting nucleic acid from a sample suspected of containing one or more microorganisms; and
b) contacting said extracted nucleic acid with a cleavage means under conditions such that said extracted nucleic acid forms one or more secondary structures, and said cleavage means cleaves said secondary structures to produce one or more cleavage products.

### Claim 20 (depends on 19)

The method of claim 19, further comprising the step of separating said cleavage products.

### Claim 21 (depends on 19)

The method of claim 19, further comprising the step of detecting said cleavage products.

### Claim 22 (depends on 21)

The method of claim 21, further comprising comparing said detected cleavage products generated from cleavage of said extracted nucleic acid isolated from said sample with separated cleavage products generated by cleavage of nucleic acids derived from one or more reference microorganisms.

### Claim 32 (depends on 31)

The method of claim 31, wherein said nuclease is selected from the group consisting of Cleavase™ BN, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and the Saccharomyces cerevisiae Rad1/Rad10 complex.

### Claim 33 (depends on 19)

The method of claim 19, wherein said nucleic acid of step (a) is substantially single-stranded.

### Claim 34 (depends on 19)

The method of claim 19, wherein said nucleic acid is RNA.

### Claim 35 (depends on 19)

The method of claim 19, wherein said nucleic acid is DNA.

### Claim 36 (depends on 19)

The method of claim 19, wherein said nucleic acid of step (a) is double stranded.

### Claim 37 (depends on 36)

The method of claim 36, wherein said treating of step (b) comprises:
i) rendering said double-stranded nucleic acid substantially single-stranded; and
ii) exposing said single-stranded nucleic acid to conditions such that said single-stranded nucleic acid has secondary structure.

### Claim 38 (depends on 37)

The method of claim 37, wherein said double-stranded nucleic acid is rendered substantially single-stranded by increased temperature.

### Claim 39 (depends on 19)

The method of claim 19 wherein said microorganism comprises bacteria.

### Claim 40 (depends on 39)

The method of claim 39 wherein said bacteria are selected from the group comprising members of the genera Campylobacter, Escherichia, Mycobacterium, Salmonella, Shigella and Staphylococcus.

### Claim 41 (depends on 40)

The method of claim 40 wherein said members of the genus Mycobacterium comprise strains of multi-drug resistant Mycobacterium tuberculosis.

### Claim 42 (depends on 19)

The method of claim 19 wherein said microorganism comprises virus.

### Claim 43 (depends on 42)

The method of claim 42 wherein said virus is selected from the group comprising hepatitis C virus and simian immunodeficiency virus.

### Claim 44

A method for treating nucleic acid comprising an oligonucleotide containing microbial gene sequences, comprising:
a) providing
i) a cleavage means in a solution containing manganese; and
ii) nucleic acid substrate containing microbial gene sequences;
b) treating said nucleic acid substrate with increased temperature such that said substrate is substantially single-stranded;
c) reducing said temperature under conditions such that said single-stranded substrate forms one or more cleavage structures;
d) reacting said cleavage means with said cleavage structures so that one or more cleavage products are produced; and
e) detecting said one or more cleavage products.
